German sci-tech giant Merck is very optimistic about its prospects in the Chinese market and will continue to strengthen its ...
On the stiffness scale, Merck saw a 3.0 reduction in the pimicotinib group and 0.57 dip in the placebo cohort. The figures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback